The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects

Gut

Volumn 44, Issue 4, 1999, Pages 557-562

  Niemi, M ^a   Kervinen, K ^a   Rantala, A ^a   Kauma, H ^a   Paivansalo M ^a   Savolainen, M J ^a   Lilja, M ^a   Kesaniemi Y A ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Apolipoprotein E; Cholesterol; Diabetes; Gallstone disease; Impaired glucose tolerance

Indexed keywords

GLUCOSE; INSULIN; LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLELITHIASIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; INCIDENCE; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032902232     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.4.557     Document Type: Article

References (38)

1. Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man (second of two parts). N Engl J Med 1978;299:1221-7.
2. Maclure KM, Hayes KC, Colditz GA, et al. Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med 1989;321:563-9.
3. Muhrbeck O, Ahlberg J. Prevalence of gallstone disease in a Swedish population. Scand J Gastroenterol 1995;30:1125-8.
4. Attili AF, Capocaccia R, Carulli N, et al. Factors associated with gallstone disease in the MICOL experience. Hepatology 1997;26:809-18.
5. Johnston DE, Kaplan MM. Pathogenesis and treatment of gallstones. N Engl J Med 1993;328:412-21.
6. Petiti DB, Friedman GD, Klatsky AL. Association of a history of gallbladder disease with a reduced concentration of high-density-lipoprotein cholesterol. N Engl J Med 1981;23:1396-8.
7. Thijs C, Knipschild P, Brombacher P. Serum lipids and gallstones: a case-control study. Gastroenterology 1990;99:843-9.
8. Diehl AK, Haffner SM, Hazuda HP, et al. Coronary risk factors and clinical gallbladder disease: an approach to the prevention of gallstones? Am J Public Health 1987;77:841-5.
9. De Santis A, Attili AF, Corradini SG, et al. Gallstones and diabetes: a case-control study in a free living population sample. Hepatology 1997;25:787-90.
10. Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J 1987;113:433-40.
11. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
12. Poirier J, Davignon J, Bouthillier D, et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-9.
13. Kuusisto J, Koivisto K, Kervinen K, et al. Association of apolipoprotein E phenotypes with late-onset Alzheimer's disease: population-based study. BMJ 1994;309:636-8.
14. Kervinen K, Savolainen MJ, Salokannel J, et al. Apolipoprotein E and B polymorphisms - longevity factors assessed in nonagenarians. Atherosclerosis 1994;105:89-95.
15. Kesäniemi YA, Ehnholm C, Miettinen TA. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 1987;80:578-81.
16. Kervinen K, Södervik H, Mäkelä J, et al. Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? Gastroenterology 1996;110:1785-90.
17. Juvonen T, Kervinen K, Kairaluoma MI, et al. Gallstone cholesterol content is related to apolipoprotein E polymorphism. Gastroenterology 1993;104:1806-13.
18. Bertomeu A, Ros E, Zambon D, et al. Apolipoprotein E polymorphism and gallstones. Gastroenterology 1996;111:1603-10.
19. Lipid Research Clinics Program. Manual of Laboratory operations. Lipid and lipoprotein analysis. Bethesda, MD: DHEW Publications, National Institutes of Health, 1974.
20. Rantala AO, Päivänsalo M, Kauma H, et al. Hyperinsulinemia and carotid atherosclerosis in hypertensive and control subjects. Diabetes Care 1998;21:1188-93.
21. World Health Organization. WHO Expert Committee on Diabetes Mellitus: Second Report. Technical Report Series no 646. Geneva: World Health Organisation, 1980.
22. Menzel H-J, Utermann G. Apolipoprotein E phenotyping from serum by Western blotting. Electrophoresis 1986;7:492-5.
23. Ehnholm C, Lukka M, Kuusi T, et al. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986;27:227-35.
24. Liinamaa MJ, Kervinen K, Hannuksela ML, et al. Effect of apolipoprotein E phenotype on plasma lipids and lipoproteins in alcohol abusers. Alcohol Clin Exp Res 1997;21:606-12.
25. Gardner MJ, Altman DG. Statistics with confidence. London: BMJ Publishing Group, 1989.
26. Van Erpecum KJ, Carey MC. Apolipoprotein E4: another risk factor for cholesterol gallstone formation? Gastroenterology 1996;111:1764-7.
27. Danziger GR, Gordon H, Schoenfield LJ, et al. Lithogenic bile in siblings of young women with cholelithiasis. Mayo Clin Proc 1972;47:762-6.
28. Kesäniemi YA, Koskenvuo M, Vuoristo M, et al. Biliary lipid composition in monozygotic and dizygotic pairs of twins. Gut 1989;30:1750-6.
29. Juvonen T, Savolainen MJ, Kairaluoma MI, et al. Polymorphism at the apolipoprotein B, A-I and cholesteryl ester transfer protein gene loci in patients with gallbladder disease. J Lipid Res 1995;36:804-12.
30. Honoré LH. The lack of a positive association between symptomatic cholesterol cholelithiasis and clinical diabetes mellitus: a retrospective study. J Chron Dis 1980;33:465-9.
31. Hayes PC, Patrick A, Roulston JE, et al. Gallstones in diabetes mellitus: prevalence and risk factors. Eur J Gastroenterol Hepatol 1992;4:55-9.
32. Scragg RKR, Calvert GD, Oliver JR. Plasma lipids and insulin in gallstone disease: a case control study. BMJ 1984;289:521-5.
33. Busch N, Matern S. Current concepts in cholesterol gallstone pathogenesis. Eur J Clin Invest 1991;21:453-60.
34. Portincasa P, van Erpecum KJ, van de Meeberg PC, et al. Apolipoprotein E4 genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after extracorporeal shock-wave lithotripsy. Hepatology 1996;24:580-7.
35. Vlahcevic ZR, Cooper Bell C Jr, Buhac I, et al. Diminished bile acid pool size in patients with gallstones. Gastroenterology 1970;59:165-73.
36. Grundy SM, Metzger AL, Adler RD. Mechanisms of lithogenic bile formation in American Indian women with cholesterol gallstones. J Clin Invest 1972;51:3026-43.
37. Terkeltaub RA, Dyer CA, Martin J, et al. Apolipoprotein (Apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular Apo E and demonstration of Apo E binding to urate crystals in vivo. J Clin Invest 1991;87:20-6.
38. Ma J, Yee A, Brewer B, et al. Amyloid-associated proteins α1-antichymo-trypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 1994;372:92-4.